Epidemiological pattern and time trends in testicular germ-cell tumors: A single institution 20-year experience

Clinical and Translational Oncology

Volumn 8, Issue 8, 2006, Pages 588-593

  Saera, Jorge Molina ^a   Urtasun, Jorge Aparicio ^a   Beveridge, Roberto Díaz ^a   Abad, Laura Palomar ^a   Ortiz, Alejandra Giménez ^a   Lorenzo, José Ponce ^a   Salcedo, Joaquín Montalar ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Incidence; Stage; Temporary evolution; Testicular germ cell tumors

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; CISPLATIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; VINBLASTINE; VINCRISTINE;

ADJUVANT THERAPY; ADOLESCENT; ADULT; ADVANCED CANCER; ARTICLE; CANCER INCIDENCE; CANCER RECURRENCE; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CHI SQUARE TEST; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DATA COLLECTION METHOD; EARLY CANCER; EARLY DIAGNOSIS; GERM CELL TUMOR; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; ORCHIECTOMY; OUTCOMES RESEARCH; OVERALL SURVIVAL; RISK REDUCTION; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; TESTIS TUMOR; TIME; INCIDENCE; MIDDLE AGED; NEOPLASM; PATHOLOGY; RETROSPECTIVE STUDY; SURVIVAL;

ADOLESCENT; ADULT; EARLY DIAGNOSIS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, GERM CELL AND EMBRYONAL; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TESTICULAR NEOPLASMS;

EID: 33749070344     PISSN: 1699048X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12094-006-0064-2     Document Type: Article

References (26)

1. Garner MJ, Turner MC, Ghadirian P, Krewski D. Epidemiology of testicular cancer: An overview. Int J Cancer. 2005; 116:331-9.
2. Huyghe E, Matsuda T, Thonneau P. Increasing incidence of testicular cancer wordwide: A review. J Urol. 2003;170:5-11.
3. Purdue MP, Devesa SS, Sigurdson AJ, McGlynn KA. International patterns and trends in testis cancer incidence. Int J Cancer. 2005;115:822-7.
4. Bosl GJ, Motzer RJ. Testicular germ-cell cancer. New Engl J Med. 1997;337:242-55.
5. Jones RH, Vasey PA. Part I: Testicular cancer-management of early disease. Lancet Oncol. 2003;4:730-7.
6. Scholz M, Holtl W. Stage I testicular cancer. Curr Opin Urol. 2003;13:473-6.
7. Jones RH, Vasey PA. Part II: Testicular cancer-management of advanced disease. Lancet Oncol. 2003;4:758-47.
8. Sonneveld DJ, Hoekstra HJ, Van Der Graaf WT, et al. The changing distribution of stage in nonseminomatous testicular germs cell tumours, from 1977 to 1996. BJU Int. 1999;84:68-74.
9. Hermanek P, Sobin LH: UICC: TNM Classification of Malignant Tumours, 5th edition. Berlin: Springer; 1997.
10. International Germ Cell Cancer Collaborative Group. International Germ Cell Consensus Classification: A prognostic factor-based staging system for metastatic germ-cell cancers. J Clin Oncol. 1997;15:594-605.
11. Huddard RA, Birtle AJ. Recent advances in the treatment of testicular cancer. Expert Rev Anticancer Ther. 2005;5:123-38.
12. Boyle P. Testicular cancer: The challenge for cancer control. Lancet Oncol. 2004;5: 56-61.
13. Germá-Lluch JR, García del Muro X, Maroto P, et al. Clinical pattern and therapeutic results achieved in 1490 patients with germ-cell tumors of the testis: The experience of the Spanish Germ-Cell Cancer Group (GG). Eur Urol. 2002;42:553-62.
14. Mostofi FK, Sesterhenn IA, Davis CJ Jr. Developments in histopathology of testicular germ cell tumors. Semin Urol. 1988;6:171-88.
15. Pearce N, Sheppard RA, Howard JK, et al. Time trends and occupational differences in cancer of the testis in New Zealand. Cancer. 1987;59:1677-82.
16. Moller H, Skakkebaek NE. Testicular cancer and cryptorchidism in relation to prenatal factors: Case-control studies in Denmark. Cancer Causes Control. 1997;8:904-12.
17. Weir HK, Marrett LD, Kreiger N, et al. Pre-natal and peri-natal exposures and risk of testicular germ-cell cancer. Int J Cancer. 2000;87:438-43.
18. Pettersson A, Kaijser M, Richiardi L, et al. Women smoking and testicular cancer: One epidemic causing another? Int J Cancer. 2004;109:941-4.
19. Heimdal K, Fossa SD, Johansen A. Increasing incidence and changing stage distribution of testicular carcinoma in Norway 1970-87. Br J Cancer. 1990;62:277-8.
20. Krag Jacobsen G, Barlebo H, Olsen J, et al. Testicular germ cell tumours in Denmark 1976-80. Pathology of 1058 consecutive cases. Acta Radiol Oncol. 1984;23:239-47.
21. Mead GM, Stenning SP, Parkinson MC, et al. The second Medical Research Council study of prognostic factors in nonseminomatous germ cell tumours. J Clin Oncol. 1992;10:85-94.
22. Moul JW, Paulson DF, Dodge RK, Walther PJ. Delay in diagnosis and survival in testicular cancer: Impact of effective therapy and changes during 18 years. J Urol. 1990;143:520-3.
23. Thornhill JA, Fennelly JJ, Kelly DG, et al. Patients' delay in the presentation of testis cancer in Ireland. Br J Urol. 1987;59:447-51.
24. Chilvers CED, Saunders M, Bliss JM, et al. Influence of delay in diagnosis on prognosis in testicular teratoma. Br J Cancer. 1989;59:126-8.
25. Kuczyc M, Bokemeyer C, Hartmann JT. Advances in our understanding of the biology, new diagnostic approaches and recent treatment strategies for testicular germ cell cancer. World J Urol. 2004;22:1.
26. Balk C, Witjes JA. Advances in the management of testicular cancer. Expert Rev Anticancer Ther. 2004;4:669-77.